Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTMWL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,132
Award facts
- Contract value 100% obligated
- $21,132.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,132.20 to AmerisourceBergen Drug Corp for the supply of Beyfortus 50 mg/0.5 ml syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Beyfortus is a monoclonal antibody used for respiratory syncytial virus (RSV) prevention in infants and young children, representing a specialized pharmaceutical product within the federal medical supply chain.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FTMWL?
SPE2DB25FTMWL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FTMWL worth?
The government has obligated $21,132 on SPE2DB25FTMWL.
Is contract SPE2DB25FTMWL an order under another contract?
Yes. SPE2DB25FTMWL is a delivery order under SPE2DB25D7056, an indefinite delivery contract.
Was contract SPE2DB25FTMWL competed?
The extent of competition for SPE2DB25FTMWL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award